Received Jan 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z008866 | — |
the patient has not experienced any clinical side effects; a dose of PROQUAD was given instead of MMRII to a 32 year old patient; This spontaneous report was received from a medical assistant and refers to a 32-year-old male patient. The patient's medical history was exposure to measles. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 05-Dec-2025, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), Powder and solvent for solution for injection, (lot #Z008866, expiration date: 10-Nov-2026) 1 dosage form, total (route of administration and anatomical location were not provided) as prophylaxis instead of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), the patient was exposed to measles and needed a booster (Wrong product administered). The vaccine was reconstituted with sterile diluent (Hollister-Stier STERILE DILUENT) (lot # and expiration date were not provided). The patient had not experienced any clinical side effects. The reporter was requesting information on needing to revaccinate.
Medical History/Concurrent Conditions: Environmental exposure
Sterile diluent